PA30157: The molecular biology and treatment of cancer
[Page last updated: 15 October 2020]
Academic Year: | 2020/1 |
Owning Department/School: | Department of Pharmacy & Pharmacology |
Credits: | 6 [equivalent to 12 CATS credits] |
Notional Study Hours: | 120 |
Level: | Honours (FHEQ level 6) |
Period: |
|
Assessment Summary: | EX 100% |
Assessment Detail: |
|
Supplementary Assessment: |
|
Requisites: | |
Description: | Aims: To familiarise the student with recent advances in molecular and cellular processes underlying tumour development and its treatment. Learning Outcomes: On successful completion of this unit, the student should be able to demonstrate knowledge and understanding of the disease process in cancer, and the complexity of its treatment, and give examples of current treatment regimes in particular clinical settings. Skills: Scientific skills (T/F/A) Study skills, handling information, working with others (T/F) Problem solving (T/F) Content: Chemical mutagenesis. Cell biology of tumour development including apoptosis, oncogenes and tumour suppressor genes. The molecular mechanisms of action of the major classes of drugs currently in use and their shortcomings. |
Programme availability: |
PA30157 is Optional on the following programmes:Department of Biology & Biochemistry
|
Notes:
|